Hemophilia Arthropathy Clinical Trial
Official title:
Assesment of Quality of Life by Functional Independance Score in Hemophilia Patients
To asses quality of life in patients with hemophilia clinically.-
-To avoid or minimize structural damage to goints and muscles by making patients aware of
importance of rehabilitation
Hemophilia is a blood-clotting disorder caused by a deficiency in factor VIII (FVIII) or
factor IX (FIX), which manifests itself through bleeding in the muscles and joints [1].
There are three categories, depending on the percentage of the blood-clotting factor: severe
hemophilia (<1% FVIII/IX), characterised by spontaneous bleeding; moderate hemophilia (1-5%
FVIII/FIX), with bleeding from slight injuries; and mild hemophilia (>5-40% FVIII/FIX) with
bleeding during surgical procedures or from severe injuries(2).(3) Hemophilia C (a deficiency
of Factor XI) is encountered, but its effect on clotting is far less pronounced than A or B
Hemophilic arthropathy of the ankle causes pain and deterioration in gait, causing
disability. Although some physiotherapy modalities are effective in the management of acute
bleeding, the results are unknown in chronic arthropathy Due to the progression of hemophilic
arthropathy and the resulting deterioration of the joint, deformities such as the estriction
of motion (4). Physiotherapy through the RICE method (Rest, Ice, Compression, and Elevation)
has been described for the improvement of acute joint injuries (5)as well as in the
management of hemarthrosis in patients with hemophilia (6) Treatment of the ankle with
physical therapy is complicated because it involves a small joint surface that bears
significant ranges of body weight and the joint limitation alters biomechanical movement
during walking(7) Prevention of musculoskeletal morbidity is an important objective in the
treatment of hemophilia. Efficacy of such therapy has classically been measured by
quantifying the extent of arthropathy using a joint scoring (8)(9)
Design of the Functional Independence Score in Hemophilia
Patients with hemophilia and their therapists were asked to list activities that could be
affected by hemophilia. These were categorized according to the International Classification
of Functioning, Disability and Health (ICF) (10)Activities that were considered unsafe to
perform were excluded from the assessment. Other activities such as the use of transport,
education and employment - that could not be assessed objectively in the clinic were also
excluded. We finally included seven activities under three categories - selfâcare, transfers
and locomotion (Table 1). Each activity was graded from 1 to 4 according to the amount of
assistance required to perform the activity. Each activity and level of independence was
clearly defined to reduce interobserver variation.core from 1 to 4 in each area:
1. = the subject is unable to perform the activity, or needs complete assistance to perform
the activity;
2. = the subject needs partial assistance/aids/modified (9) (10) instruments/modified
environment to perform the activity;
3. = the subject is able to perform the activity without aids or assistance, but with
slight discomfort. He is unable to perform the activity like his healthy peers 11 4= the
subject is able to perform the activity without any difficulty like other healthy pears
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05589662 -
Clinical, Functional and Musculoskeletal Differences Between Adult Patients With Hemophilia and Their Healthy Peers
|
||
Not yet recruiting |
NCT03499522 -
Pain in Patients With Congenital Coagulopathies
|
||
Completed |
NCT04491318 -
COVID-19 Quarantine on Musculoskeletal Status in Hemophilia
|
||
Active, not recruiting |
NCT04754997 -
Effect of Exercise in Pediatric Hemophilia
|
N/A | |
Completed |
NCT06331091 -
Physiotherapy and Reaction Time in Hemophilia
|
N/A | |
Active, not recruiting |
NCT04715100 -
Pain and Joint Status With Psychosocial Factors in Patients With Hemophilia
|
||
Recruiting |
NCT06352216 -
Prevalence of Synovitis in Patients With Haemophilia A
|